+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lung Cancer Diagnostics"

From
From
From
From
Global Lung Cancer Screening Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Lung Cancer Screening Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Lung Cancer. Edition No. 4 - Product Thumbnail Image

Lung Cancer. Edition No. 4

  • Book
  • May 2014
  • 616 Pages
Loading Indicator

The Lung Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of tests and technologies that can detect and diagnose lung cancer. These tests can range from imaging techniques such as X-ray, CT scan, and MRI, to molecular tests such as gene sequencing and biomarker analysis. The goal of these tests is to detect lung cancer at an early stage, when it is most treatable. The Lung Cancer Diagnostics market is highly competitive, with many companies offering a variety of tests and technologies. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Hologic, and Becton Dickinson. Show Less Read more